Natural history of pelvic organ prolapse in postmenopausal women.
Catherine S Bradley, M Bridget Zimmerman, Yingwei Qi...
https://pubmed.ncbi.nlm.nih.gov/17400845/Actively Recruiting
Led by University of Sao Paulo General Hospital · Updated on 2026-01-22
86
Participants Needed
1
Research Sites
139 weeks
Total Duration
Researchers are comparing two surgical methods for treating apical compartment pelvic organ prolapse POP in women vaginal mesh surgery and robotic-assisted abdominal mesh surgery. The study aims to determine if vaginal mesh surgery is not less effective than the abdominal approach and to evaluate the safety of vaginal mesh use. This is a prospective, randomized non-inferiority study focusing on women diagnosed with stage II or higher apical prolapse who need surgery. Participants will be randomly assigned to one of two surgical treatments. One group will receive vaginal prolapse repair using the Splentisae mesh, which involves anterior colporrhaphy and mesh anchoring to the sacrospinous ligaments. The other group will undergo robot-assisted laparoscopic abdominal repair using the Upsylonae mesh, which fixes the mesh to the vaginal walls and sacral promontory. The study plans include 43 participants per group, considering possible loss to follow-up. During the study, patients will be evaluated at one month after surgery and then every six months up to two years. Researchers will assess objective cure rates based on prolapse stage and monitor surgical complications. They will also evaluate clinical factors such as mesh erosion, pain, and quality of life using a validated questionnaire adapted for Portuguese speakers. The total follow-up period aims to provide comprehensive data on outcomes and safety.
CONDITIONS
Vaginal Mesh Surgery Versus Robotic-assisted Abdominal Mesh Surgery in the Treatment of Apical Prolapse - Prospective Randomized Non-inferiority Study
M
Marcelo Hisano, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Sao Paulo General Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Day of surgery and immediate recovery period
Participants undergo either vaginal mesh surgery or robotic-assisted abdominal mesh surgery for apical prolapse.
1 surgical visit (in-person)
Duration - Up to 1 month postoperatively
Participants are monitored for surgical complications and recovery progress after surgery.
1 visit at 1 month postoperatively (in-person)
Duration - Up to 24 months after surgery
Participants have follow-up evaluations to assess objective cure rate and clinical outcomes such as pain and quality of life.
Visits every 6 months for up to 24 months postoperatively (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Catherine S Bradley, M Bridget Zimmerman, Yingwei Qi...
https://pubmed.ncbi.nlm.nih.gov/17400845/Eric Rovner, Christopher Chermansky, Elisabetta Costantini...
https://pubmed.ncbi.nlm.nih.gov/38837735/Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien
https://pubmed.ncbi.nlm.nih.gov/15273542/C-Y Zhang, Z-J Sun, J Yang...
https://pubmed.ncbi.nlm.nih.gov/32426903/Thais Villela Peterson, Rodrigo Ambar Pinto, G Willy Davila...
https://pubmed.ncbi.nlm.nih.gov/29549393/C F Maher, K K Baessler, M D Barber...
https://pubmed.ncbi.nlm.nih.gov/30572743/Christopher Maher, Ellen Yeung, Nir Haya...
https://pubmed.ncbi.nlm.nih.gov/37493538/Priscylla Helouyse Angelo, Neila Alves de Queiroz, Alethéa Cury Rabelo Leitão...
https://pubmed.ncbi.nlm.nih.gov/31851458/Victoria L Handa, Elizabeth Garrett, Susan Hendrix...
https://pubmed.ncbi.nlm.nih.gov/14749630/Catherine O Hudson, Gina M Northington, Robert H Lyles...
https://pubmed.ncbi.nlm.nih.gov/25181374/University of Sao Paulo General Hospital
Lead Sponsor